World-wide trends in patterns of care for breast, cervical and ovarian cancers – The VENUSCANCER project
Watch here
The CONCORD programme documented wide global differences in survival trends, still persistent in 2010-2014, for women diagnosed with breast cancer (66% in India; over 90% in the US and Australia), cervical (52% in Ecuador; 77% in Korea) or ovarian (16% in India; 57% in Costa Rica) cancers.
The VENUSCANCER project, embedded in the CONCORD programme, examines whether global differences in survival are attributable to differences in disease biology between populations, or patterns of care, or socio-economic status.
Cancer registries were invited to submit data for a single year of complete incidence during 2015-2018, for which availability and completeness of high-resolution variables (e.g., stage, staging procedures, biomarkers, treatment) were highest. VENUSCANCER offered financial support to 11 registries in low- and middle-income countries to enable collection of these data.
During this webinar we will discuss the world-wide adherence to international clinical guidelines for cervical and ovarian cancer.
